Covid-19 Antivirals Taskforce

(asked on 7th June 2021) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what are the (1) remit, and (2) powers, of the COVID-19 Antivirals Taskforce; to whom will the Chair of the Taskforce report; and by what date.


Answered by
Lord Bethell Portrait
Lord Bethell
This question was answered on 22nd June 2021

The Antivirals Taskforce was launched on 20 April 2021 with the aim of having two effective oral antiviral treatments which are deployable by autumn/winter 2021 to be taken in an outpatient setting.

The role of the Chair is to oversee the work of the Taskforce, ensuring it meets its core objectives and to work with a range of stakeholders to meet this ambitious timescale. The Chair also leads and is supported by the Antivirals Expert Advisory Group, which provides advice and recommendations to the Chair on various activities within the Taskforce. This is not a statutory appointment and there is no power to confer functions directly on the Chair. The Chair reports to the Secretary of State for Health and Social Care.

Reticulating Splines